A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Clinical trial NCT06524544 · RECRUITING
Trial details
- NCT number
- NCT06524544
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-02
- Primary completion
- 2028-12-31
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.